|
End-of-day quote
Shenzhen S.E.
2026-09-28
|
5-day change | 1st Jan Change | ||
| 10.35 CNY | +1.07% |
|
+4.97% | -12.21% |
| 09-20 | Newland Pharmaceutical Co., Ltd.(XSEC:301277) added to S&P Global BMI Index | CI |
| 08-21 | Newland Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| Market Cap | 4.06B 605M 532M 503M 456M 857M 58.04B 862M 6.02B 2.32B 29.65B 2.27B 2.22B 95.2B | P/E 2024 |
22.3x | P/E 2025 | 38x |
|---|---|---|---|---|---|
| Enterprise Value | 3.35B 499M 438M 415M 376M 707M 47.85B 710M 4.96B 1.91B 24.44B 1.87B 1.83B 78.47B | EV / Sales 2024 |
4.23x | EV / Sales 2025 | 5.81x |
| Free-Float |
24.38% | Yield 2024 |
2.89% | Yield 2025 | 1.7% |
| 1 day | +1.07% | ||
| 1 week | +4.97% | ||
| Current month | +1.37% | ||
| 1 month | -0.96% | ||
| 3 months | +18.97% | ||
| 6 months | -11.84% | ||
| Current year | -12.21% |
| 1 week | 10.19 |  | 10.55 |
| 1 month | 9.54 | | 10.58 |
| Current year | 8.45 | | 13.28 |
| 1 year | 8.45 | | 13.84 |
| 3 years | 6.64 | | 18.38 |
| 5 years | 6.64 | | 18.38 |
| 10 years | 6.64 | | 18.38 |
| Manager | Title | Age | Since |
|---|---|---|---|
Lu Wei Zhang
CEO | Chief Executive Officer | 55 | 2015-07-31 |
Qing Kui Wang
DFI | Director of Finance/CFO | 47 | 2020-10-04 |
Wen Yang Zhang
ADM | Chief Administrative Officer | 37 | 2019-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Jian Zhong Xie
CHM | Chairman | 61 | 2009-03-31 |
Wan Min Liu
BRD | Director/Board Member | 59 | 2005-08-31 |
Lu Wei Zhang
BRD | Director/Board Member | 55 | 2005-08-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.07% | +4.97% | -19.08% | -9.03% | 598M | |
| +0.11% | +2.76% | +63.52% | +115.51% | 1,055B | |
| +0.27% | +0.73% | +51.33% | +73.10% | 654B | |
| +0.73% | +0.88% | +20.70% | +73.89% | 467B | |
| -1.36% | -0.39% | +40.20% | +41.03% | 348B | |
| +1.34% | +5.47% | +23.37% | +31.30% | 275B | |
| -0.48% | -0.06% | +13.56% | +12.36% | 258B | |
| +0.85% | +8.42% | +53.17% | +55.45% | 224B | |
| +0.85% | +1.40% | +35.78% | +101.47% | 187B | |
| -0.30% | -10.41% | -27.62% | -61.04% | 171B | |
| Average | +0.14% | +0.60% | +25.49% | +43.40% | 363.89B | |
| Weighted average by Cap. | -0.11% | +1.32% | +40.68% | +69.04% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 726M 108M 95.22M 90.07M 81.69M 153M 10.39B 154M 1.08B 416M 5.31B 406M 398M 17.04B | 672M 100M 88.14M 83.37M 75.61M 142M 9.62B 143M 997M 385M 4.91B 376M 368M 15.77B |
| Net income | 174M 25.88M 22.76M 21.53M 19.52M 36.68M 2.48B 36.87M 258M 99.39M 1.27B 97.14M 95.04M 4.07B | 121M 18.07M 15.89M 15.03M 13.63M 25.61M 1.73B 25.75M 180M 69.4M 886M 67.83M 66.37M 2.84B |
| Net Debt | -804M -120M -105M -99.66M -90.38M -170M -11.5B -171M -1.19B -460M -5.87B -450M -440M -18.86B | -713M -106M -93.45M -88.39M -80.16M -151M -10.2B -151M -1.06B -408M -5.21B -399M -390M -16.72B |
Employees
981
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-28 | CN¥10.35 | +1.07% | 3,015,245 |
| 26-09-24 | CN¥10.24 | -2.01% | 2,491,470 |
| 26-09-23 | CN¥10.45 | +0.29% | 3,420,604 |
| 26-09-22 | CN¥10.42 | 0.00% | 5,147,352 |
- Stock Market
- Stocks
- 301277 Stock
Select your edition
All financial news and data tailored to specific country editions
